CatalystMacro

ADARX PHARMACEUTICALS SEEKS IPO ON STRONG COLLABORATION DEAL WITH ABBVIE - SEEKINGALPHA

IPO filing highlights AbbVie collaboration as key catalyst for listing.

What changed

IPO filing highlights AbbVie collaboration as key catalyst for listing.

Why it matters

IPO filing highlights AbbVie collaboration as key catalyst for listing. — impact context not separately stored; see What changed.

Sources